Literature DB >> 2405798

Diabetic diarrhea. Pathophysiology, diagnosis, and management.

K I Ogbonnaya1, R Arem.   

Abstract

Idiopathic diarrhea is a common complication of diabetes mellitus. It occurs frequently, but not exclusively, in patients with poorly controlled insulin-dependent diabetes who also have evidence of diabetic peripheral and autonomic neuropathy. Associated steatorrhea is common and does not necessarily imply a concomitant gastrointestinal disease. The diarrhea is often intermittent; it may alternate with periods of normal bowel movements, or with constipation. It is typically painless, and occurs during the day as well as at night and may be associated with fecal incontinence. Multiple pathogenic mechanisms have been implicated, autonomic neuropathy, bacterial overgrowth, and pancreatic exocrine insufficiency being the most important underlying aberrations. However, diabetic diarrhea does not have a uniform and unequivocal pathogenesis. The diagnosis depends on a judicious clinical assessment accompanied by a stepwise laboratory evaluation, which allows the differentiation idiopathic diabetic diarrhea from the many other causes of diarrhea that can occur in diabetic and nondiabetic patients. The management can be difficult but many therapies, including antibiotics to eradicate bacterial overgrowth, as well as antidiarrheal agents, oral and topical clonidine, and somatostatin analogues may be effective in controlling diabetic diarrhea.

Entities:  

Mesh:

Year:  1990        PMID: 2405798     DOI: 10.1001/archinte.150.2.262

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  12 in total

Review 1.  Diagnosis and treatment of diabetic autonomic neuropathy.

Authors:  D Ziegler
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 2.  Gastrointestinal disturbances in diabetes.

Authors:  Manju Chandran; Neelima V Chu; Steven V Edelman
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

3.  Restoration of Na+/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid loss.

Authors:  Peijian He; Luqing Zhao; Lixin Zhu; Edward J Weinman; Roberto De Giorgio; Michael Koval; Shanthi Srinivasan; C Chris Yun
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

4.  Ramosetron might be useful for treating diabetic diarrhea with a rapid small bowel transit time.

Authors:  Tae Hee Lee; Joon Seong Lee
Journal:  Korean J Intern Med       Date:  2012-12-28       Impact factor: 2.884

5.  Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes.

Authors:  F L Iber; S Parveen; M Vandrunen; K B Sood; F Reza; R Serlovsky; S Reddy
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

Review 6.  Non-insulin-dependent (type II) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-12-15       Impact factor: 8.262

7.  Somatostatin-mediated inhibitory postsynaptic potential in sympathetically denervated guinea-pig submucosal neurones.

Authors:  K Z Shen; A Surprenant
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

8.  Effects of somatostatin analog SMS 201-995 on enterotoxigenic diarrhea.

Authors:  R N Greenberg
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

Review 9.  Diabetes-induced mechanophysiological changes in the small intestine and colon.

Authors:  Mirabella Zhao; Donghua Liao; Jingbo Zhao
Journal:  World J Diabetes       Date:  2017-06-15

Review 10.  An update on the diagnosis and treatment of diabetic somatic and autonomic neuropathy.

Authors:  Shazli Azmi; Ioannis N Petropoulos; Maryam Ferdousi; Georgios Ponirakis; Uazman Alam; Rayaz A Malik
Journal:  F1000Res       Date:  2019-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.